Updated treatment recommendations for systemic treatment: from the ESMO non-oncogene addicted-metastatic NSCLC Living Guideline†

L E L Hendriks; F Cortiula; D Martins-Branco; E Mariamidze; S Popat; M Reck; ESMO Guidelines Committee

doi:10.1016/j.annonc.2025.06.004

Updated treatment recommendations for systemic treatment: from the ESMO non-oncogene addicted-metastatic NSCLC Living Guideline†

L E L Hendriks^*
, F Cortiula
, D Martins-Branco
, E Mariamidze
, S Popat
, M Reck
, ESMO Guidelines Committee

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1223-1227
Number of pages	5
Journal	Annals of Oncology
Volume	36
Issue number	10
Early online date	18 Jun 2025
DOIs	https://doi.org/10.1016/j.annonc.2025.06.004
Publication status	Published - 1 Oct 2025

Keywords

Chemotherapy (ChT)
combination treatment
guideline
immune checkpoint inhibitor (ICI)
metastatic non-oncogene-addicted non-small cell lung cancer (mNSCLC)
treatment

Access to Document

10.1016/j.annonc.2025.06.004

Cite this

@article{02e203508a22429d8d9732f5c06a4580,

title = "Updated treatment recommendations for systemic treatment: from the ESMO non-oncogene addicted-metastatic NSCLC Living Guideline†",

keywords = "Chemotherapy (ChT), combination treatment, guideline, immune checkpoint inhibitor (ICI), metastatic non-oncogene-addicted non-small cell lung cancer (mNSCLC), treatment",

author = "Hendriks, \{L E L\} and F Cortiula and D Martins-Branco and E Mariamidze and S Popat and M Reck and \{ESMO Guidelines Committee\}",

year = "2025",

month = oct,

day = "1",

doi = "10.1016/j.annonc.2025.06.004",

language = "English",

volume = "36",

pages = "1223--1227",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "10",

}

TY - JOUR

T1 - Updated treatment recommendations for systemic treatment

T2 - from the ESMO non-oncogene addicted-metastatic NSCLC Living Guideline†

AU - Hendriks, L E L

AU - Cortiula, F

AU - Martins-Branco, D

AU - Mariamidze, E

AU - Popat, S

AU - Reck, M

AU - ESMO Guidelines Committee

PY - 2025/10/1

Y1 - 2025/10/1

KW - Chemotherapy (ChT)

KW - combination treatment

KW - guideline

KW - immune checkpoint inhibitor (ICI)

KW - metastatic non-oncogene-addicted non-small cell lung cancer (mNSCLC)

KW - treatment

U2 - 10.1016/j.annonc.2025.06.004

DO - 10.1016/j.annonc.2025.06.004

M3 - Comment/Letter to the editor

SN - 0923-7534

VL - 36

SP - 1223

EP - 1227

JO - Annals of Oncology

JF - Annals of Oncology

IS - 10

ER -